420 with CNW – Workers’ Compensation Being Modified to Incorporate Medical Cannabis in Canada

You would expect that with more than 17 years of existence in Canada, medical cannabis should have already led to policy changes in various aspects of life in the country. However, if the claims of injured workers are anything to go by, workers’ compensation guidelines have been slow in changing to accommodate this form of treatment. Now matters are beginning to shift as the discussion below shows.

More Workers Winning in Tribunals

Mellissa Ellsworth is just one of 10 patients who have won hearings in Nova Scotia’s workers’ comp tribunal set up to assess whether the Workers’ Compensation Board should cover the cost of medical marijuana. It took her five years to get this approval.

Alberta’s board has so far also accepted to cover the medical marijuana costs of 10 workers who were injured on the job. New Brunswick shines in this regard because it has so far approved 71 patients’ applications for medical cannabis costs coverage under workers’ comp policies.

It is saddening that patients have to endure years of pain as their applications slowly make their way through the red tape of the Workers’ Compensation Boards in the different provinces and territories. For example, the neurological pain experienced by Melissa Ellsworth led her to take a total of 26 pills on a daily basis just to function as a normal human. She now takes only cannabis and enjoys a better quality of life.

The good news amidst all this is that for each patient who gets approval, more are encouraged to table their requests before the different boards. Eventually, medical cannabis will become a normal form of treatment and no patient will have to go through what the pioneers like Melissa Ellsworth had to endure to get approval.

Doctors’ Prescriptions Rarely Considered

You would think that the different Workers’ Compensation Boards would attach some weight to the recommendations provided by the primary healthcare providers of the patients who apply for coverage.

However, only Quebec recognizes and acts upon those recommendations. Other boards convene their own medical team sittings to assess the eligibility of a patient for medical cannabis. Why should this happen when Health Canada screens patients before giving them a medical cannabis card?

Caps on Daily Cannabis Consumption

Nearly all provinces and territories that are even willing to consider paying for medical cannabis for injured workers impose a three gram cap on how much medical cannabis a patient can claim coverage for each day.

While there may be valid reasons for this cap, it would be reasonable for these boards to acknowledge that different patients have different needs, so mechanisms should be available for those who need more to be covered without major hassles. Even Health Canada allows patients to grow hundreds of cannabis plants if they need a lot on a daily basis for their treatment. But, workers’ comp boards still insist on three grams a day!

But, There’s Progress…

Amidst this huge cloud hovering over injured workers in Canada, winds of change are slowly picking up. Last year, New Brunswick set the stage by passing medical cannabis guidelines. Prince Edward Island followed suit, and now Nova Scotia is drafting its own set of guidelines.

While all this is happening in Canada, one wonders what the situation is here in the U.S. With most marijuana businesses still struggling to access banking services, it is hard to picture what patients may be going through if they wish to have their medical cannabis costs covered by workers’ comp insurance. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America (OTCQB: MCOA) decry the slow rate at which workers’ compensation is evolving to accommodate medical cannabis. This isn’t only denying patients a viable treatment option, but it is also limiting the investment opportunities that would boost the economy.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – This is How Much Recreational Pot Canadians Bought in 2018

If you were asked to make a random guess about how much weed Canadians bought (and presumably consumed) since recreational marijuana was legalized in October last year, what would you say? Well, Statistics Canada released recreational cannabis sales data and the figures are surprising, to say the least.

The statistics show that in October last year, Canadians bought recreational cannabis worth $32.7 million while November sales amounted to $40.4 million. In December, Canadians bought recreational cannabis products worth $41.9 million.

These figures are considered to be highly reliable because the Canadian marijuana market is highly regulated. You should therefore not doubt that the first three months of legal recreational pot resulted in total sales of $115 million. That is shocking, given all the hype that accompanied the lead up to legalization.

However, a number of factors may explain why annual recreational cannabis sales are likely to be far less than was predicted.

First, the persistent supply shortages have made it hard for all Canadian who would like to use weed to buy the substance as often as they would like. Without weed on the shelves, where would the sales come from? Many licensed producers predict that it may take years for them to ramp up their production to a level that can meet the current demand.

Secondly, Health Canada has also played a part in dampening the performance of the recreational cannabis sector. The regulator has been very slow in processing the applications for the different entities that would like to become licensed producers/cultivators of cannabis in the country. There are claims that Health Canada takes several months or even years to make a decision on an application. This sluggish way of conducting their business has made it hard for enough producers to be active in the country, hence the supply shortages.

Another reason for the low recreational cannabis sales has to do with a shortage of packaging and processing facilities. There are reports that harvested cannabis takes unnecessarily long to reach the shelves of retail outlets because the few processers licensed in the country cannot handle the volume of weed available for processing and packaging.

Not surprisingly, the packaging and processing problem also goes back to Health Canada who have been slow in issuing processing or packaging licenses to interested players.

Finally, the provinces may also have a role to play in the dismal sales statistics. For example, Ontario has only been selling recreational cannabis through the state-run online outlets. While there are plans to open offline stores, the current sale in online stores alone has reduced the potential sales that would have been made in the densely populated cities within the province.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America Inc. (OTCQB: MCOA) look forward to a speedy resolution of all the limiting factors above so that the Canadian cannabis industry can reach its full potential.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Four Ways Cannabis Entrepreneurs are Using AI in Sales and Ecommerce

As the marijuana industry has grown and become more widely accepted, many tech companies have introduced new products to enable the cannabis industry. Here are the four major AI products that marijuana businesses are deploying to boost sales and make ecommerce more successful.

Chatbots

The explosion of interest in cannabis means that the limited staff of marijuana companies can easily be overwhelmed if they decided to address each person’s queries without the help of AI.

Chatbots have been introduced to engage customers and potential customers quickly and efficiently by providing all the information one needs. For example, the chatbot can take a potential customer through the different cannabis strains that may help to ease the symptoms that the client is experiencing. These bots have revolutionized the way cannabis businesses attend to their customers at a time when people make a query and expect an answer to it “yesterday.”

Finding Leads

One of the hardest aspects of selling is to find prospects. Cannabis businesses are turning to AI tools, such as Node, to generate lists of potential customers. This is a more reliable method than the traditional way of buying lists of prospects who often turned out to be uninterested in what one was selling.

Filtering Prospects

It is one thing to get a list of prospects and it is another matter to filter them into warm or cold prospects. That is where AI comes in. Artificial intelligence systems are now available to analyze data in order to establish which particular products a potential customer has been searching for.

The findings of such AI systems can help sales personnel to concentrate their efforts on those individuals that are most likely to make a purchase instead of spending time and effort on people with a low possibility of making a purchase. An example of this type of AI system is Netra. This system understands consumer preferences by analyzing the visual content on different social media platforms.

Sales Forecasting

As you may know, there is always a multitude of demands competing for the resources that any company has at its disposal. The same applies to cannabis businesses. One of the best ways to determine how to allocate those scarce resources is by forecasting sales so that intelligent decisions can be made for the company.

AI systems have been deployed to forecast cannabis sales so that businesses can plan for the future more effectively, such as by making decisions on when to scale up or down.

While some people may think that AI has come to take cannabis jobs, the truth is that AI can only go so far. For example, AI fails dismally at comprehending the nuances of language based on different contexts and humans have to step in at such points. Cannabis businesses should therefore regard AI as an aid to their workforce rather than as a tool to cut back on human employees. Green Hygienics Holdings Inc. (OTCQB: GRYN) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) look forward to seeing even more AI products in every aspect of the cannabis industry.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Cannabis Could Prevent Chronic Traumatic Encephalopathy, Researchers Reveal

Many athletes, such as footballers, commit suicide or die as a result of the brain trauma caused while they engage in contact sports. Chronic traumatic endephalopathy (CTE), a degenerative neurological condition, is one such brain trauma disease that conventional medicine has found so hard to prevent or treat partly because the condition can only be diagnosed posthumously. Now a number of scientists and researchers are suggesting that cannabis may help to prevent or alleviate the symptoms of this disease whose victims are mainly athletes (particularly footballers).

One study conducted in Israel found that the use of cannabis improved blood flow to the brain and prevented brain tissues from dying. While this study was conducted on rats and mice with head trauma, it brings hope for a solution to a problem from which 99 percent of all dead NFL players suffered, researchers say.

Another study conducted in the U.S. concluded that cannabis possesses neuro-protective properties because of the antioxidants it contains. In fact, Kyle Turley, a retired NFL player, uses cannabis to treat the traumatic brain injury he suffers from resulting from his days as a player. Turley was also a friend of another NFL player, Junior Seau, who fatally shot himself in 2012. Brain specialists who examined samples of Seau’s brain found that his suicidal tendency was due to CTE.

Apart from causing people to be suicidal, CTE causes depression, aggression, confusion, dementia and mood swings.

Turley is now an avid advocate for the use of cannabis to treat neurological conditions, especially among athletes.

His mission isn’t farfetched because a number of companies have been developing cannabis-based remedies for different neurological conditions. For example, KannaLife Sciences is developing a synthetic cannabis pill that is intended to prevent CTE in athletes. The company also makes other CBD-based remedies.

Another company, GW Pharmaceuticals, has already obtained FDA approval for Epidiolex, a CBD-based drug that can treat two forms of rare pediatric epilepsy. Epilepsy is a neurological condition, just like CTE. Epidiolex has already proved to be effective for some of the kids with the forms of epilepsy for which it was developed.

It should be noted that treating brain injury isn’t achieved by CBD alone. A study whose findings were published in The American Surgeon showed that patients who suffered brain injuries and tested positive for THC suffered fewer fatalities than those who didn’t test positive for THC.

Such findings provide good news to Green Hygienics Holdings Inc. (OTCQB: GRYN) and other players in the cannabis industry like Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) because it offers a possible solution to a problem (CTE) that could be affecting millions of athletes.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – What is CBD, and what is its Relationship with THC?

People who have heard about CBD-infused drinks, cosmetics and pet food may be wondering why that cannabis extract isn’t attracting as much polarized attention as THC. Read on and learn everything that you need to know about CBD and THC, and why CBD is gaining in popularity in nearly every industry.

A Brief Primer on Cannabinoids…

The cannabis plant has more than 100 different compounds within it. These are called cannabinoids and terpenes, so you should therefore not imagine that the cannabis plant has only two compounds. However, two of the most abundant cannabinoids in the cannabis plant are CBD (cannabidiol) and THC (tetrahydrocannabinol).

THC is the psychoactive cannabinoid that makes cannabis consumers “high” while CBD isn’t psychoactive.

Marijuana vs. Hemp?

Cannabis is a general term used to refer to a family of plants that have similar compounds (cannabinoids). Marijuana and hemp are therefore members of the same family.

However, hemp has a very small amount of THC in it. The U.S. federal government describes a given plant in the cannabis family as hemp if that plant has less than 0.3 percent concentration of THC. By the same token, marijuana is the other member of the cannabis family that has THC levels that are higher than the threshold for the hemp plant.

Remember, “hemp” and “marijuana” are arbitrary terms given to the same plant only that the level of THC determines which of those two words you will use to refer to the plant you are looking at.

Why is CBD Readily Available Yet Marijuana is Illegal?

As already mentioned, CBD is one of the non-psychoactive compounds found in the cannabis plant. This cannabinoid has several medicinal properties, such as anxiety, pain and insomnia relief.

Recently, President Trump signed into law the Farm Bill of 2018 and this law changed the legal status of hemp to an agricultural product (just like soy, corn or any other plant). Consequently, extracting CBD oil from hemp doesn’t break any U.S. law.

In contrast, marijuana is a Schedule 1 controlled substance that is illegal at the federal level. However, dozens of states have legalized medical marijuana and nearly a dozen have legalized adult-use marijuana.

The laws and attitudes surrounding marijuana haven’t affected the reputation of CBD and that is why it is widely available.

Do Consumers of CBD Face Any Safety Risks?

Interestingly, nearly all the literature available on CBD says that it is safe for consumption. However, little is known about how this compound may interact with other substances, such as conventional medications, in the body.

Additionally, CBD extracts haven’t been used for a long enough time to assess their effects on pregnant women and their unborn babies. Caution is therefore recommended for people in high-risk categories (expectant mothers and babies, for example).

As you can see, CBD seems set to continue on its forward march now that hemp is an agricultural product that can be widely cultivated for various purposes. Cannabis industry players like Marijuana Company of America, Inc. (OTCQB: MCOA) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) would like to see a time when marijuana is accepted the way hemp is now accepted.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

Outside Investment, New Technology Support Growing Cannabis Industry

CannabisNewsWire Editorial Coverage: Revolutionary innovations and advancements within the cannabis industry are drawing significant investment from big corporations.

  • Technology currently in development will make it easier to consume active ingredients in cannabis.
  • Advances have attracted investment for the technology’s use in tobacco as well as cannabis.
  • These improvements could move consumers to healthier forms of consumption than smoking.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has benefited from recent investment by Altria to support its innovative research and design work. Canopy Growth Corporation (NYSE: CGC) (TSX: WEED) has received substantial investment from a beverage company, which will support the development of cannabis drinks. Within the sector, Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) is in the process of acquiring an organic grower. Outside investment is bolstering Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON), a cannabis company with global reach. And another innovator, GW Pharmaceuticals Plc (NASDAQ: GWPH) (OTC: GWPRF), has run successful trials on…

Read More >>

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

Receive Text Alerts from CannabisNewsWire: Text “Cannabis” to 21000

For more information please visit https://www.CannabisNewsWire.com and or https://CannabisNewsWire.News

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

DISCLAIMER: CannabisNewsWire (CNW) is the source of the Article and content set forth above. References to any issuer other than the profiled issuer are intended solely to identify industry participants and do not constitute an endorsement of any issuer and do not constitute a comparison to the profiled issuer. The commentary, views and opinions expressed in this release by CNW are solely those of CNW. Readers of this Article and content agree that they cannot and will not seek to hold liable CNW for any investment decisions by their readers or subscribers. CNW is a news dissemination and financial marketing solutions provider and is NOT registered broker-dealers/analysts/investment advisers, hold no investment licenses and may NOT sell, offer to sell or offer to buy any security.

The Article and content related to the profiled company represent the personal and subjective views of the Author, and are subject to change at any time without notice. The information provided in the Article and the content has been obtained from sources which the Author believes to be reliable. However, the Author has not independently verified or otherwise investigated all such information. None of the Author, CNW, or any of their respective affiliates, guarantee the accuracy or completeness of any such information. This Article and content are not, and should not be regarded as investment advice or as a recommendation regarding any particular security or course of action; readers are strongly urged to speak with their own investment advisor and review all of the profiled issuer’s filings made with the Securities and Exchange Commission before making any investment decisions and should understand the risks associated with an investment in the profiled issuer’s securities, including, but not limited to, the complete loss of your investment.

CNW HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and CNW undertakes no obligation to update such statements.

420 with CNW – Oklahoma City School Board Passes Marijuana Policy

Voters in Oklahoma approved a ballot measure last year in June making medical marijuana legal in the state. Recently, the school district in Oklahoma City passed its own medical marijuana policy to clarify what employees and students could or could not do now that medical marijuana is legal in the state.

On Monday this week (January 14), the Oklahoma City Public Schools Board released its marijuana policy in which the district asserted that it would not take any action against any employee who holds a medical marijuana license.

However, the same policy also had a clause that barred employees from possessing marijuana within school premises or during office hours even if such an employee is licensed to use medical marijuana.

The policy also stipulated that while students would be allowed to have access to, and consume medical marijuana, employees in the schools aren’t allowed to administer that marijuana to the students.

Instead, the policy states that a private location would be provided so that the caregiver of a student can administer the medical marijuana from that location. Caregivers would also be solely responsible for bringing the medical marijuana and taking it away after the student has used or consumed it.

The policy warns that disciplinary action would be taken against any student or employee who violates the school district’s marijuana policy.

Additionally, the policy states that the school district will be free to alter the policy if the federal funding of the district is jeopardized in any way by the marijuana policy or its implementation. Ultimately, the school district will adhere to any restrictions or instructions given by the federal government regarding medical marijuana.

These provisions in the policy show how large the shadow of the federal government hovering over the entire country is on matters of marijuana.

So far, more than 30,000 people have applied for medical marijuana licenses since August when residents were allowed to start applying for the cards. A patient whose application is approved has to pay $100 in order to receive their license from the Department of Health. People who are at least 18 years old are eligible to apply for a medical marijuana license if a doctor recommends them to apply for one.

The action taken by the school district is a step in the right direction because it clarifies what employees and students should expect if they want to consume medical marijuana. Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), Green Hygienics Holdings Inc. (OTCQB: GRYN) and the entire marijuana industry welcome the positive action taken by the Oklahoma City Public Schools Board.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Ohio Residents Petition for More Medical Marijuana Qualifying Conditions

Toward the end of this month, a special committee will sit to assess the different petitions that Ohioans submitted calling for additional conditions to be included on the list of ailments for which one can obtain a medical cannabis card.

The meeting this month comes after the end of a window within which people could send in their requests for the conditions they want to see on the qualifying list for access to medical cannabis.

Medical marijuana became legal in 2016 and 21 qualifying conditions were listed in that law. However, the law also granted the Medical Marijuana Board permission to review that list and add more conditions once each year.

The sale of medical marijuana is scheduled to start sometime this month and already more than 4,000 residents have secured medical marijuana cards. According to estimates, three in 10 Ohioans could qualify for a medical marijuana card even if the list of qualifying conditions stays as it was when the enabling law was passed.

The window within which interested parties could submit their petitions for additions to the list of qualifying conditions started on Nov. 1 and ended at the stroke of midnight on December 31. By the close of the window, 110 petitions had been submitted.

Those 110 petitions are now with a committee of lawyers advising the medical board. The lawyers will select some conditions indicated in the petitions and submit their shortlist to a committee that will meet tomorrow (January 9).

That committee will decide which of the conditions on the shortlist can be forwarded to medical experts for additional review and benchmarking in other states where medical cannabis programs exist.

The experts will then report back to the committee so that a report is presented to the full Medical Marijuana Board for a final vote. The Medical Board should have made their final decision by June 30, 2019, so that the list of qualifying conditions can be updated thereafter.

Some of the conditions in the petitions received include insomnia, depression and anxiety. Others are opioid addiction, acne, fibromyalgia and chronic pain. However, it should be noted that some of the petitions mentioned conditions that already appear among the 21 qualifying conditions listed in the 2016 law.

Currently, 33 states plus the District of Columbia have legalized medical marijuana. That notwithstanding, cannabis remains a Schedule 1 substance under federal law, so it is hard for scientists to study the plant and its derivatives in this prohibitionist legal environment.

Nonetheless, there are signs that the stringent controls will ease up a bit because already, the FDA has licensed a drug derived from cannabis, and permission was granted to a group of researchers at UC San Diego to import cannabis capsules from Canada for research purposes. Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) and Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) hope that the environment will become conducive soon enough at the federal level so that the industry in the U.S. can grow based on the findings of scientific studies.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – New Zealanders to Vote on Cannabis Legalization in 2020

New Zealand is likely to be the first Asia-Pacific country to legalize recreational cannabis if the expected vote in 2020 goes in favor of legalization. Such a development will make New Zealand the third country in the world to legalize recreational marijuana.

The next general elections in 2020 will have a binding referendum spelling out how exactly the industry will be regulated and managed in case voters approve legalization.

The government announced this approach in order to avoid a situation in which voters approve legalization, and then different parties disagree on how to implement the decision of the voters. A clear example of such a situation is the Brexit issue over which Britons are divided regarding what exactly they approved when they voted to leave the EU.

The decision to include a binding referendum in the next polls was made after the government and the Green Party agreed to work together to take the matter to voters.

The Green Party was particularly vocal in the campaign to legalize recreational cannabis. They argue that it is hypocritical for members of parliament to sit quietly while a law that criminalized marijuana was in force and yet many of them confessed that they had consumed cannabis in the past.

A recent poll conducted by the New Zealand Drug Foundation found that one in three New Zealanders supports the legalization of cannabis.

However, cannabis law reform advocates are unhappy that the government hasn’t revealed what exact question will be put to voters when that binding referendum is held. The Cannabis Reform Coalition suggests that the referendum question should have two parts.

According to them, the first part of the question should be designed to ask voters whether they want adults to grow and possess cannabis for personal consumption. The second part of the question can then ask the voters to state whether they are in favor of letting adults buy cannabis from authorized/licensed premises.

Such a two-part question can help voters indicate which specific form they would like cannabis legalization to take.

It is interesting to note that cannabis may not be the only subject upon which a binding referendum will be conducted come 2020. The New Zealand government is still mulling over the possibility of including a referendum on euthanasia and another on reforming the electoral laws.

Marijuana advocates are hoping that the outcome of the binding referendum is a favorable one, since the country has a history of having voted against changing the flag of the country two years ago (2016). That particular referendum cost the country upwards of $17 million.

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and other industry players like Marijuana Company of America Inc. (OTCQB: MCOA) can only hope that the voters in New Zealand will be given accurate and detailed information upon which to base which way they vote come 2020.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

420 with CNW – Study Shows Your Working Memory May Improve After Smoking Cannabis

One of the stereotypes that surround marijuana consumers is that they become forgetful when high on cannabis. However, a new study at the University of Florida has established that such a stereotype is just a myth.

The researchers designed the study in a unique way that involved exposing rats to cannabis smoke so that they inhale it. The rats were first taught to perform a number of delayed response tasks, such as poking the nose into a feeding trough a defined number of times before getting a reward of food pellets.

Alternatively, the rats in the study were required to look for, and press a lever several times before getting their reward.

The rats were divided into two groups based on their gender. In total, 32 rats took part in this study. Females tended to have lower working memory scores when compared to the scores of the males before cannabis smoke was introduced.

The researchers compared the working memory scores of the two groups when the rats were sober and how they performed after being exposed to cannabis smoke. The results showed that there appeared to be no difference in the scores obtained by the male rats when sober and after inhaling cannabis smoke.

However, there was a marked improvement in the working memory of the female rats when they performed the delayed response tasks after being exposed to the marijuana smoke. Remember, the female rats had lower scores in the working memory tasks performed prior to the introduction of cannabis smoke.

The placebo smoke used as a control in the study didn’t trigger any changes in the cognitive performance of either the male or female rats. This leaves the only logical conclusion for the better working memory as attributable to the cannabis smoke to which the rats were exposed.

The researchers also experimented with the dosage, the timing and the route of cannabis administration. Each of these variables triggered a difference in the working memory of the rats in the study.

Consequently, the researchers concluded that the cognitive outcomes observed will vary based on the specific route, dosage and duration of cannabis administration. They called for additional research to be done on this subject so that a better understanding of the effects of cannabis on cognitive function can be attained.

Stakeholders in the cannabis sector, such as Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) and Marijuana Company of America Inc. (OTCQB: MCOA) welcome all scientific studies that help to separate fact from myth on the subject of marijuana.

More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com